INTEGRA LIFESCIENCES HOLDINGS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.38 USD | 0.00% |
|
-8.02% | -32.54% |
| Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
| Apr. 03 | Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target | MT |
Chart calendar Integra LifeSciences Holdings Corporation
d2c2dbb4fd.icg2_tmJgrbTtZrq8kU1O1qleulS3KbDYUpyyQSejT4.3vEEs-HG1O6-9_Kpmy4AFmrSGLgw8fmCOxIE_XDR23_TnW62v732m5Lw-Q~5d59aa7e636181973dbded258eea7790
Upcoming events on Integra LifeSciences Holdings Corporation
Past events on Integra LifeSciences Holdings Corporation
| 2024-02-28 08:30 am | Q4 2023 Earnings Call |
| 2024-02-28 06:00 am | Q4 2023 Earnings Release |
| 2024-01-10 01:30 pm | JPMorgan Healthcare Conference |
| 2023-12-13 08:30 am | Acquisition of Acclarent, Inc. from Ethicon, Inc by Integra LifeSciences Holdings Corporation Call |
| 2023-10-25 08:30 am | Q3 2023 Earnings Call |
| 2023-10-25 06:00 am | Q3 2023 Earnings Release |
| 2023-09-06 01:30 pm | Wells Fargo Healthcare Conference |
| 2023-07-27 08:30 am | Q2 2023 Earnings Call |
| 2023-07-26 06:30 pm | Q2 2023 Earnings Release |
| 2023-05-12 09:00 am | Annual General Meeting |
| 2023-05-04 08:30 am | Investor Day |
| 2023-04-26 08:30 am | Q1 2023 Earnings Call |
| 2023-04-26 06:00 am | Q1 2023 Earnings Release |
| 2023-02-22 08:30 am | FY 2022 Earnings Call |
| 2023-02-22 06:00 am | FY 2022 Earnings Release |
| 2023-01-11 07:30 pm | JP Morgan Healthcare Conference |
| 2022-10-26 08:30 am | Q3 2022 Earnings Call |
| 2022-10-26 06:01 am | Q3 2022 Earnings Release |
| 2022-09-12 11:05 am | Morgan Stanley Global Healthcare Conference |
| 2022-09-07 08:35 am | Wells Fargo Healthcare Conference |
Past dividends on Integra LifeSciences Holdings Corporation
| 2015-07-01 | 0 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 518 1 520 -0.16% | 1 372 1 369 0.19% | 1 542 1 540 0.14% | 1 558 1 557 0.04% | 1 542 1 545 -0.2% | 1 616 |
|
EBITDA Million USD | Released Forecast Spread | 369 374 -1.47% | 334 330 1.31% | 401 399 0.35% | 411 426 -3.43% | 370 373 -0.88% | 382 |
|
EBIT Million USD | Released Forecast Spread | 324 328 -0.99% | 240 282 -14.71% | 314 360 -12.75% | 367 370 -0.91% | 329 332 -0.8% | 341 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 60,1 0,00 - | 93,5 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
Net income Million USD | Released Forecast Spread | 50,2 59,1 -15.09% | 134 62,4 114.55% | 169 169 -0.02% | 181 190 -5.06% | 67,7 95,0 -28.7% | 117 |
|
EPS USD | Released Forecast Spread | 0,58 0,67 -13.86% | 1,57 0,74 113.51% | 1,98 1,99 -0.68% | 2,16 2,38 -9.24% | 0,84 1,21 -30.29% | 1,40 |
| Announcement Date | 19/02/20 | 18/02/21 | 23/02/22 | 22/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 406 403 0.52% | 377 362 3.99% | 398 395 0.62% | 385 378 1.82% | 398 399 -0.14% | 381 373 2.04% | 381 374 1.92% | 382 387 -1.21% | 397 399 -0.55% | 362 | 396 | 418 | 441 | 390 |
|
EBITDA Million USD | Released Forecast Spread | 105 106 -0.34% | 93,5 88,4 5.79% | 103 101 1.77% | 105 93,9 12.15% | 110 111 -1.32% | 92,3 92,8 -0.56% | 88,8 75,3 17.9% | 88,1 95,7 -7.95% | 101 104 -3.08% | 71,3 | 88,7 | 105 | 116 | 94,1 |
|
EBIT Million USD | Released Forecast Spread | 93,9 94,4 -0.57% | 84,0 78,2 7.4% | 91,4 89,8 1.74% | 93,7 82,1 14.15% | 98,8 99,2 -0.42% | 81,5 81,8 -0.36% | 65,7 64,9 1.24% | 95,2 84,6 12.49% | 80,6 93,4 -13.7% | 60,9 | 80,4 | 93,5 | 105 | 80,8 |
|
Net income Million USD | Released Forecast Spread | 45,4 42,7 6.16% | 32,9 30,6 7.51% | 44,8 39,8 12.48% | 49,9 32,7 52.5% | 52,9 51,4 3.08% | 24,2 37,0 -34.48% | 4,18 19,3 -78.27% | 19,5 35,8 -45.58% | 19,8 45,0 -55.89% | 10,3 | 25,1 | 37,3 | 43,9 | 32,2 |
|
EPS USD | Released Forecast Spread | 0,53 0,50 5.85% | 0,39 0,33 17.29% | 0,54 0,45 21.35% | 0,60 0,37 61.07% | 0,63 0,67 -6.25% | 0,29 0,44 -34.09% | 0,05 0,23 -78.49% | 0,24 0,45 -46.37% | 0,25 0,58 -57.08% | 0,10 | 0,33 | 0,45 | 0,52 | 0,41 |
| Announcement Date | 23/02/22 | 27/04/22 | 27/07/22 | 26/10/22 | 22/02/23 | 26/04/23 | 26/07/23 | 25/10/23 | 28/02/24 | - | - | - | - | - |
More events
Past sector events for Integra LifeSciences Holdings Corporation
| Today | DEXCOM, INC.: Q1 2024 Earnings Release |
| 2024-04-24 04:05 pm | CONMED CORPORATION: Q1 2024 Earnings Release |
| 2024-04-24 04:00 pm | ALIGN TECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-04-24 01:30 am | XVIVO PERFUSION AB: Q1 2024 Earnings Release |
| 2024-04-23 | SHANGHAI KINETIC MEDICAL CO., LTD: Q1 2024 Earnings Release |
| 2024-04-21 | SHANGHAI KINETIC MEDICAL CO., LTD: Q4 2023 Earnings Release |
| 2024-04-19 | LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-19 | LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-18 | WELL LEAD MEDICAL CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-18 08:00 am | ARJO AB: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IART Stock
- Calendar Integra LifeSciences Holdings Corporation
